Idorsia (IDRSF) Projected to Post Quarterly Earnings on Thursday

Idorsia (OTCMKTS:IDRSF) is projected to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share and revenue of $19.82 million for the quarter.

Idorsia Stock Performance

Shares of OTCMKTS IDRSF opened at $0.75 on Wednesday. Idorsia has a 52 week low of $0.70 and a 52 week high of $2.88. The firm has a 50-day moving average price of $0.86 and a 200 day moving average price of $1.53.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.